Jacqueline L. Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jacqueline L. Chen has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Allison J. Chen
Baylor College of Medicine, Cullen Eye Institute, Houston, Texas
1 shared publication Amanda J. Lu
Department of Ophthalmology, University of California Los Angeles, Los Angeles, California
1 shared publication- Ana Luiza Machado Ribeiro Pimentel
Faculdade de Medicina, Pontifícia Universidade Católica de Goiás
1 shared publication - Andrea Coravos
Digital Medicine Society (DiMe), Boston, MA USA
1 shared publication - Ariel Dora Stern
Hasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Prof.-Dr.-Helmert-Str.2-3, Potsdam, Brandenburg, 14482, Germany, +49 33155093950
1 shared publication - Caroline Marra
Verily Life Sciences LLC, Dallas, Texas
1 shared publication
Latest Publications
- Open Access
- 26 February 2026
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (5) , 101130
Assessment of Correctness, Content Omission, and Risk of Harm in Large Language Model Responses to Ophthalmology Continuing Medical Education Questions
- 26 February 2026
- Published by Elsevier in Ophthalmology Science
- Vol. 6 (5) , 101130
Open AccessAssessment of Correctness, Content Omission, and Risk of Harm in Large Language Model Responses to Ophthalmology Continuing Medical Education Questions
- Open Access
- 27 December 2025
- Published by Elsevier in Ophthalmology Glaucoma
- Vol. 9 (3) , 302-308
The Association between Socioeconomic Status and Structural or Functional Baseline Measurements for Patients Receiving a Trabeculectomy
- 27 December 2025
- Published by Elsevier in Ophthalmology Glaucoma
- Vol. 9 (3) , 302-308
Open AccessThe Association between Socioeconomic Status and Structural or Functional Baseline Measurements for Patients Receiving a Trabeculectomy
- Open Access
- 17 March 2025
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 23, eRW1045
Phacoviscocanalostomy versus phacotrabeculectomy to treat glaucoma associated with cataracts: a meta-analysis
Objective: To compare the effectiveness and safety of phacoviscocanalostomy and phacotrabeculectomy in treating combined glaucoma and cataracts. Methods: A systematic review and meta-analysis were conducted following the PRISMA guidelines. The PubMed, Web of Science, Cochrane, and Embase databases were searched for randomized controlled trials or observational studies comparing phacotrabeculectomy to phacoviscocanalostomy in patients with glaucoma and cataracts. Statistical analysis was used to compare the efficacy (intraocular pressure reduction, mean deviation of the visual field, and failure rates) and safety
- 17 March 2025
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 23, eRW1045
Open AccessPhacoviscocanalostomy versus phacotrabeculectomy to treat glaucoma associated with cataracts: a meta-analysis
Objective: To compare the effectiveness and safety of phacoviscocanalostomy and phacotrabeculectomy in treating combined glaucoma and cataracts. Methods: A systematic review and meta-analysis were conducted following the PRISMA guidelines. The PubMed, Web of Science, Cochrane, and Embase databases were searched for randomized controlled trials or observational studies comparing phacotrabeculectomy to phacoviscocanalostomy in patients with glaucoma and cataracts. Statistical analysis was used to compare the efficacy (intraocular pressure reduction, mean deviation of the visual field, and failure rates) and safety
- Open Access
- 3 April 2020
- Published by Springer Nature in npj Digital Medicine
- Vol. 3 (1) , 50
Quantifying the use of connected digital products in clinical research
Over recent years, the adoption of connected technologies has grown dramatically, with potential for improving health care delivery, research, and patient experience. Yet, little has been documented about the prevalence and use of connected digital products (e.g., products that capture physiological and behavioral metrics) in formal clinical research. Using 18 years of data from ClinicalTrials.gov, we document substantial growth in the use of connected digital products in clinical trials (~34% CAGR) and show that these products have been used across all phases of research and by a diverse group of trial sponsors. We identify four distinct use cases for how such connected products have been integrated within clinical trial design and suggest implications for various stakeholders engaging in clinical research.
- 3 April 2020
- Published by Springer Nature in npj Digital Medicine
- Vol. 3 (1) , 50
Open AccessQuantifying the use of connected digital products in clinical research
Over recent years, the adoption of connected technologies has grown dramatically, with potential for improving health care delivery, research, and patient experience. Yet, little has been documented about the prevalence and use of connected digital products (e.g., products that capture physiological and behavioral metrics) in formal clinical research. Using 18 years of data from ClinicalTrials.gov, we document substantial growth in the use of connected digital products in clinical trials (~34% CAGR) and show that these products have been used across all phases of research and by a diverse group of trial sponsors. We identify four distinct use cases for how such connected products have been integrated within clinical trial design and suggest implications for various stakeholders engaging in clinical research.